USANA Health Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
USANA Health Sciences, Inc. (USNA) filed a Current Report on Form 8-K on May 5, 2026. The filing announces the release of financial results for the first quarter ended April 4, 2026. The company is incorporated in Utah and trades on the New York Stock Exchange.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release and management commentary. It does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the attached exhibits (99.1 and 99.2) which are not included in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release and management commentary for comparative analysis.
Guidance, Outlook, and Management Commentary
- Management Commentary: The company announced the posting of a "Management Commentary" document on its corporate website.
- Conference Call: Executives scheduled a conference call with investors to discuss the results, featuring brief remarks followed by a question-and-answer session.
- Disclosure Status: The information is furnished under Regulation FD but is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached Press Release (Exhibit 99.1).
- Review the "Management Commentary" (Exhibit 99.2) for details on margin trends and operational challenges.
- Confirm the date and access details for the investor conference call mentioned in the filing.
- Check the company website (www.usana.com) for the full text of the exhibits referenced in this 8-K.